| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.621 | 0.003 | 0.635 | Antidiuretic hormone antagonist | 0.293 0.004 CHEMBL392363 0.635 0.003 CHEMBL237772 0.407 0.004 CHEMBL3526965 0.035 0.03 CHEMBL237987 | CHEMBL237772 | |
| 0.604 | 0.002 | 0.621 | Vasopressin 2 antagonist | 0.17 0.004 CHEMBL392363 0.621 0.002 CHEMBL237772 0.364 0.003 CHEMBL3526965 0.071 0.009 CHEMBL237987 | CHEMBL237772 | |
| 0.597 | 0.003 | 0.597 | Vasopressin 1A antagonist | 0.135 0.005 CHEMBL392363 0.339 0.003 CHEMBL237772 0.274 0.004 CHEMBL3526965 | ||
| 0.583 | 0.005 | 0.583 | Diuretic | 0.258 0.029 CHEMBL392363 0.254 0.03 CHEMBL237772 0.243 0.032 CHEMBL3526965 0.312 0.02 CHEMBL237987 | ||
| 0.565 | 0.003 | 0.565 | Vasopressin 1 antagonist | 0.17 0.005 CHEMBL392363 0.382 0.004 CHEMBL237772 0.311 0.004 CHEMBL3526965 | ||
| 0.422 | 0.025 | 0.422 | Cardiotonic | 0.365 0.035 CHEMBL392363 0.247 0.085 CHEMBL237772 0.246 0.085 CHEMBL3526965 0.347 0.04 CHEMBL3542202 | ||
| 0.403 | 0.057 | 0.403 | MAP kinase kinase 6 inhibitor | |||
| 0.395 | 0.105 | 0.52 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.387 0.113 CHEMBL392363 0.291 0.225 CHEMBL237772 0.311 0.198 CHEMBL3526965 0.281 0.24 CHEMBL3542202 0.52 0.025 CHEMBL237987 | CHEMBL237987 | |
| 0.371 | 0.097 | 0.371 | Analgesic | 0.267 0.168 CHEMBL237772 0.236 0.196 CHEMBL237987 | ||
| 0.245 | 0.003 | 0.245 | Antidiuretic hormone agonist | 0.032 0.012 CHEMBL392363 0.044 0.006 CHEMBL237772 0.064 0.005 CHEMBL3526965 | ||
| 0.227 | 0.003 | 0.227 | Vasopressin 2 agonist | 0.018 0.01 CHEMBL392363 0.029 0.005 CHEMBL237772 0.068 0.004 CHEMBL3526965 | ||
| 0.224 | 0.005 | 0.224 | Purinergic P2 antagonist | 0.183 0.008 CHEMBL392363 0.159 0.009 CHEMBL237772 0.153 0.01 CHEMBL3526965 0.109 0.018 CHEMBL237987 | ||
| 0.263 | 0.051 | 0.263 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.249 | 0.058 | 0.249 | Anticonvulsant | |||
| 0.172 | 0.002 | 0.172 | Follicle-stimulating hormone antagonist | 0.023 0.008 CHEMBL392363 0.031 0.005 CHEMBL237772 0.061 0.003 CHEMBL3526965 | ||
| 0.171 | 0.003 | 0.171 | Follicle-stimulating hormone agonist | 0.026 0.012 CHEMBL237772 0.076 0.004 CHEMBL3526965 | ||
| 0.169 | 0.005 | 0.169 | Purinergic P2X antagonist | 0.151 0.005 CHEMBL392363 0.125 0.006 CHEMBL237772 0.123 0.006 CHEMBL3526965 0.073 0.016 CHEMBL237987 | ||
| 0.162 | 0.005 | 0.28 | Oxytocin antagonist | 0.048 0.019 CHEMBL392363 0.28 0.004 CHEMBL237772 0.061 0.015 CHEMBL3526965 | CHEMBL237772 | |
| 0.256 | 0.1 | 0.256 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.192 0.167 CHEMBL3526965 | ||
| 0.216 | 0.065 | 0.305 | Nitric-oxide synthase stimulant | 0.17 0.152 CHEMBL392363 0.171 0.151 CHEMBL237772 0.181 0.126 CHEMBL3526965 0.279 0.018 CHEMBL3542202 0.305 0.01 CHEMBL237987 | CHEMBL237987 | |
| 0.137 | 0.005 | 0.137 | Potassium channel (Ca-activated) blocker | |||
| 0.304 | 0.175 | 0.304 | MAP kinase 1 inhibitor | |||
| 0.129 | 0.004 | 0.129 | Purinergic P2X7 antagonist | 0.114 0.004 CHEMBL392363 0.095 0.005 CHEMBL237772 0.09 0.005 CHEMBL3526965 0.049 0.015 CHEMBL237987 | ||
| 0.206 | 0.083 | 0.206 | EphB2 antagonist | |||
| 0.145 | 0.025 | 0.199 | Hedgehog signaling inhibitor | 0.176 0.015 CHEMBL392363 0.105 0.057 CHEMBL237772 0.199 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.129 | 0.024 | 0.13 | Potassium channel (Voltage-sensitive) activator | 0.13 0.023 CHEMBL237987 | CHEMBL237987 | |
| 0.112 | 0.007 | 0.123 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.123 0.005 CHEMBL392363 0.108 0.008 CHEMBL237772 0.073 0.025 CHEMBL3526965 | CHEMBL392363 | |
| 0.207 | 0.103 | 0.207 | MAP kinase kinase 3 inhibitor | 0.2 0.123 CHEMBL3526965 | ||
| 0.118 | 0.031 | 0.118 | Interleukin 12 antagonist | 0.112 0.037 CHEMBL392363 0.101 0.052 CHEMBL237772 0.103 0.049 CHEMBL237987 | ||
| 0.134 | 0.053 | 0.164 | Papain-like protease (SARS coronavirus) inhibitor | 0.132 0.057 CHEMBL392363 0.133 0.055 CHEMBL237772 0.127 0.065 CHEMBL3526965 0.151 0.033 CHEMBL3542202 0.164 0.023 CHEMBL237987 | CHEMBL237987 | |
| 0.089 | 0.018 | 0.1 | Potassium channel (Tandem pore domain) blocker | 0.076 0.044 CHEMBL392363 0.088 0.019 CHEMBL237772 0.1 0.009 CHEMBL237987 | CHEMBL237987 | |
| 0.125 | 0.058 | 0.155 | Interleukin 1b antagonist | 0.155 0.037 CHEMBL237987 | CHEMBL237987 | |
| 0.107 | 0.041 | 0.145 | Potassium channel activator | 0.097 0.051 CHEMBL392363 0.145 0.022 CHEMBL237987 | CHEMBL237987 | |
| 0.115 | 0.052 | 0.174 | Interleukin 2 antagonist | 0.131 0.031 CHEMBL392363 0.116 0.052 CHEMBL237772 0.174 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.095 | 0.034 | 0.19 | p38 MAP kinase inhibitor | 0.132 0.023 CHEMBL392363 0.19 0.014 CHEMBL237772 0.065 0.048 CHEMBL237987 | CHEMBL237772 | |
| 0.091 | 0.041 | 0.091 | MAP kinase 11 inhibitor | 0.081 0.047 CHEMBL237772 | ||
| 0.162 | 0.113 | 0.162 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.075 | 0.026 | 0.075 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.228 | 0.179 | 0.665 | Antiobesity | 0.665 0.014 CHEMBL3542202 | CHEMBL3542202 | |
| 0.066 | 0.017 | 0.066 | Antiviral (Hepatitis D) | |||
| 0.053 | 0.014 | 0.053 | Delayed rectifier potassium channel activator | 0.042 0.021 CHEMBL237987 | ||
| 0.053 | 0.014 | 0.053 | Potassium channel KCNQ activator | 0.042 0.021 CHEMBL237987 | ||
| 0.057 | 0.02 | 0.074 | Smo receptor antagonist | 0.045 0.026 CHEMBL237772 0.074 0.014 CHEMBL237987 | CHEMBL237987 | |
| 0.089 | 0.053 | 0.099 | Bcr-Abl kinase inhibitor | 0.099 0.042 CHEMBL237987 | CHEMBL237987 | |
| 0.044 | 0.013 | 0.077 | Calcium release-activated channel blocker | 0.035 0.02 CHEMBL392363 0.077 0.004 CHEMBL237987 | CHEMBL237987 | |
| 0.08 | 0.049 | 0.08 | Viral attachment inhibitor | |||
| 0.131 | 0.104 | 0.131 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.124 | 0.099 | 0.133 | Death-associated protein kinase 1 inhibitor | 0.133 0.074 CHEMBL237987 | CHEMBL237987 | |
| 0.043 | 0.019 | 0.043 | Potassium channel Kv1.1 blocker | 0.036 0.031 CHEMBL237987 | ||
| 0.095 | 0.071 | 0.153 | Glutamate (mGluR7) agonist | 0.091 0.08 CHEMBL237772 0.153 0.011 CHEMBL3542202 0.126 0.025 CHEMBL237987 | CHEMBL3542202 | |
| 0.039 | 0.015 | 0.039 | Catechol O-methyltransferase inhibitor | 0.032 0.025 CHEMBL3526965 | ||
| 0.073 | 0.052 | 0.076 | MAP kinase 14 inhibitor | 0.066 0.059 CHEMBL237772 0.076 0.05 CHEMBL237987 | CHEMBL237987 | |
| 0.157 | 0.135 | 0.157 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.072 | 0.052 | 0.161 | Nav1.8 sodium channel blocker | 0.075 0.048 CHEMBL237772 0.161 0.012 CHEMBL237987 | CHEMBL237987 | |
| 0.079 | 0.062 | 0.079 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.099 | 0.083 | 0.099 | MAP kinase 13 inhibitor | |||
| 0.073 | 0.059 | 0.083 | CC chemokine receptor antagonist | 0.083 0.049 CHEMBL237772 | CHEMBL237772 | |
| 0.033 | 0.021 | 0.033 | Protein kinase C beta II inhibitor | |||
| 0.108 | 0.099 | 0.108 | Tyrosine-protein kinase receptor antagonist | |||
| 0.11 | 0.105 | 0.122 | Interleukin 1 antagonist | 0.122 0.086 CHEMBL237987 | CHEMBL237987 | |
| 0.084 | 0.081 | 0.087 | Chemokine receptor antagonist | 0.084 0.082 CHEMBL392363 0.087 0.078 CHEMBL237772 | CHEMBL237772 | |
| 0.049 | 0.046 | 0.072 | CC chemokine 2 receptor antagonist | 0.072 0.024 CHEMBL237772 | CHEMBL237772 | |
| 0.04 | 0.037 | 0.071 | Stearoyl-CoA desaturase inhibitor | 0.071 0.014 CHEMBL3542202 | CHEMBL3542202 | |
| 0.064 | 0.063 | 0.064 | Vanilloid antagonist | |||
| 0.047 | 0.045 | 0.047 | Cannabinoid CB2 receptor agonist | |||
| 0.019 | 0.02 | 0.02 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.02 0.018 CHEMBL237987 | CHEMBL237987 | |
| 0.065 | 0.069 | 0.31 | Glutamate receptor agonist | 0.31 0.005 CHEMBL392363 0.163 0.015 CHEMBL237987 | CHEMBL392363 | |
| 0.092 | 0.1 | 0.112 | TRKA antagonist | 0.096 0.094 CHEMBL392363 0.112 0.075 CHEMBL237987 | CHEMBL237987 | |
| 0.111 | 0.126 | 0.233 | Farnesoid X receptor antagonist | 0.233 0.014 CHEMBL237987 | CHEMBL237987 | |
| 0.09 | 0.11 | 0.126 | CDK3/cyclin E inhibitor | 0.126 0.047 CHEMBL237987 | CHEMBL237987 | |
| 0.036 | 0.056 | 0.086 | Glutamate (mGluR5) agonist | 0.086 0.009 CHEMBL392363 | CHEMBL392363 | |
| 0.032 | 0.053 | 0.229 | Glutamate (mGluR group III) agonist | 0.068 0.016 CHEMBL392363 0.229 0.004 CHEMBL237987 | CHEMBL237987 | |
| 0.064 | 0.091 | 0.075 | Stem cell growth factor agonist | 0.075 0.073 CHEMBL237987 | CHEMBL237987 | |
| 0.117 | 0.146 | 0.152 | MAP kinase 3 inhibitor | 0.152 0.064 CHEMBL237987 | CHEMBL237987 | |
| 0.086 | 0.116 | 0.109 | Nav1.5 sodium channel blocker | 0.109 0.07 CHEMBL237772 | CHEMBL237772 | |
| 0.014 | 0.044 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | 0.018 0.014 CHEMBL237987 | CHEMBL237987 | |
| 0.138 | 0.171 | 0.189 | Growth factor agonist | 0.163 0.114 CHEMBL3542202 0.189 0.074 CHEMBL237987 | CHEMBL237987 | |
| 0.024 | 0.066 | 0.125 | Glutamate (mGluR4) agonist | 0.033 0.026 CHEMBL392363 0.125 0.004 CHEMBL237987 | CHEMBL237987 | |
| 0.16 | 0.205 | 0.258 | Neuropeptide Y2 antagonist | 0.258 0.049 CHEMBL3542202 0.21 0.103 CHEMBL237987 | CHEMBL3542202 | |
| 0.127 | 0.173 | 0.158 | Death-associated protein kinase 2 inhibitor | 0.158 0.089 CHEMBL3542202 | CHEMBL3542202 | |
| 0.037 | 0.084 | 0.13 | Glutamate (mGluR) agonist | 0.13 0.017 CHEMBL392363 0.062 0.043 CHEMBL237987 | CHEMBL392363 | |
| 0.028 | 0.077 | 0.622 | Dihydroorotase inhibitor | 0.622 0.001 CHEMBL237987 | CHEMBL237987 | |
| 0.21 | 0.261 | 0.477 | Cyclophilin D inhibitor | 0.477 0.057 CHEMBL3542202 0.3 0.163 CHEMBL237987 | CHEMBL3542202 | |
| 0.104 | 0.156 | 0.141 | TRKC antagonist | 0.141 0.11 CHEMBL237987 | CHEMBL237987 | |
| 0.102 | 0.156 | 0.199 | NOS3 expression enhancer | 0.199 0.041 CHEMBL237987 | CHEMBL237987 | |
| 0.036 | 0.094 | 0.069 | Autotaxin inhibitor | 0.069 0.023 CHEMBL237987 | CHEMBL237987 | |
| 0.109 | 0.168 | 0.143 | Pregnane X receptor agonist | 0.143 0.066 CHEMBL3542202 | CHEMBL3542202 | |
| 0.16 | 0.219 | 0.195 | Nootropic | 0.195 0.165 CHEMBL392363 | CHEMBL392363 | |
| 0.023 | 0.082 | 0.078 | Glutamate (mGluR group I) agonist | 0.078 0.013 CHEMBL392363 | CHEMBL392363 | |
| 0.029 | 0.096 | 0.068 | Carnitine palmitoyltransferase 1B inhibitor | 0.068 0.012 CHEMBL237987 | CHEMBL237987 | |
| 0.016 | 0.086 | 0.034 | Cyclophilin A inhibitor | 0.034 0.018 CHEMBL237987 | CHEMBL237987 | |
| 0.025 | 0.096 | 0.686 | Dihydroorotate dehydrogenase inhibitor | 0.686 0.002 CHEMBL237987 | CHEMBL237987 | |
| 0.141 | 0.215 | 0.413 | Thyroid hormone beta antagonist | 0.413 0.05 CHEMBL237987 | CHEMBL237987 | |
| 0.045 | 0.131 | 0.217 | HIV-1 integrase inhibitor | 0.217 0.005 CHEMBL3526965 0.073 0.044 CHEMBL237987 | CHEMBL3526965 | |
| 0.167 | 0.254 | 0.408 | Interleukin 2 agonist | 0.224 0.151 CHEMBL392363 0.227 0.147 CHEMBL237772 0.408 0.025 CHEMBL3542202 | CHEMBL3542202 | |
| 0.04 | 0.127 | 0.081 | Aryl hydrocarbon receptor antagonist | 0.081 0.025 CHEMBL237987 | CHEMBL237987 | |
| 0.051 | 0.145 | 0.134 | Antineoplastic alkaloid | 0.103 0.046 CHEMBL392363 0.134 0.033 CHEMBL237772 | CHEMBL237772 | |
| 0.052 | 0.149 | 0.196 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.067 CHEMBL3542202 0.196 0.004 CHEMBL237987 | CHEMBL237987 | |
| 0.014 | 0.114 | 0.041 | Neurokinin 3 antagonist | 0.041 0.036 CHEMBL237772 | CHEMBL237772 | |
| 0.02 | 0.123 | 0.123 | Prostaglandin E2 antagonist | 0.123 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.07 | 0.174 | 0.153 | Sodium channel blocker | 0.153 0.056 CHEMBL237772 | CHEMBL237772 | |
| 0.019 | 0.127 | 0.053 | Integrin alpha2 antagonist | 0.053 0.01 CHEMBL237987 | CHEMBL237987 | |
| 0.08 | 0.191 | 0.147 | Transcription factor STAT6 inhibitor | 0.147 0.026 CHEMBL3542202 0.111 0.077 CHEMBL237987 | CHEMBL3542202 | |
| 0.018 | 0.133 | 0.101 | Prostaglandin antagonist | 0.101 0.017 CHEMBL237987 | CHEMBL237987 | |
| 0.125 | 0.242 | 0.421 | Thyroid hormone antagonist | 0.421 0.05 CHEMBL237987 | CHEMBL237987 | |
| 0.064 | 0.188 | 0.136 | Sodium channel (voltage-gated) blocker | 0.136 0.067 CHEMBL237772 | CHEMBL237772 | |
| 0.028 | 0.152 | 0.049 | CXC chemokine 1 receptor antagonist | 0.049 0.039 CHEMBL237987 | CHEMBL237987 | |
| 0.033 | 0.158 | 0.075 | Prostaglandin F2 alpha antagonist | 0.075 0.027 CHEMBL237987 | CHEMBL237987 | |
| 0.011 | 0.14 | 0.138 | TRPM8 blocker | 0.138 0.005 CHEMBL237987 | CHEMBL237987 | |
| 0.097 | 0.231 | 0.153 | 3C-like protease (Human coronavirus) inhibitor | 0.153 0.095 CHEMBL237987 | CHEMBL237987 | |
| 0.019 | 0.156 | 0.044 | Mineralocorticoid receptor antagonist | 0.044 0.04 CHEMBL392363 | CHEMBL392363 | |
| 0.012 | 0.151 | 0.046 | Purinergic P2Y14 antagonist | 0.046 0.009 CHEMBL237987 | CHEMBL237987 | |
| 0.012 | 0.156 | 0.03 | Integrin alpha2beta1 antagonist | 0.03 0.012 CHEMBL237987 | CHEMBL237987 | |
| 0.036 | 0.181 | 0.082 | Secretase beta inhibitor | 0.082 0.033 CHEMBL3542202 | CHEMBL3542202 | |
| 0.022 | 0.172 | 0.487 | Prostaglandin-E synthase inhibitor | 0.487 0.003 CHEMBL237987 | CHEMBL237987 | |
| 0.005 | 0.157 | 0.042 | Kainate receptor 5 antagonist | 0.042 0.006 CHEMBL237987 | CHEMBL237987 | |
| 0.012 | 0.166 | 0.314 | Phosphorylase inhibitor | 0.314 0.003 CHEMBL237987 | CHEMBL237987 | |
| 0.017 | 0.181 | 0.176 | Acetylcholine M5 receptor antagonist | 0.176 0.005 CHEMBL3542202 | CHEMBL3542202 | |
| 0.096 | 0.262 | 0.237 | ATPase inhibitor | 0.237 0.017 CHEMBL237987 | CHEMBL237987 | |
| 0.13 | 0.299 | 0.399 | DNA directed DNA polymerase inhibitor | 0.229 0.205 CHEMBL3542202 0.399 0.116 CHEMBL237987 | CHEMBL237987 | |
| 0.003 | 0.176 | 0.019 | Thrombopoietin agonist | 0.019 0.004 CHEMBL237987 | CHEMBL237987 | |
| 0.048 | 0.225 | 0.136 | AMP-activated protein kinase stimulant | 0.136 0.037 CHEMBL237987 | CHEMBL237987 | |
| 0.027 | 0.207 | 0.129 | Sphingosine 1-phosphate receptor 1 antagonist | 0.054 0.043 CHEMBL3542202 0.129 0.005 CHEMBL237987 | CHEMBL237987 | |
| 0.08 | 0.261 | 0.132 | Interleukin 6 antagonist | 0.132 0.12 CHEMBL237987 | CHEMBL237987 | |
| 0.003 | 0.185 | 0.016 | Integrin alpha4beta1 antagonist | 0.016 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.076 | 0.258 | 0.509 | Interleukin agonist | 0.509 0.008 CHEMBL3542202 0.278 0.06 CHEMBL237987 | CHEMBL3542202 | |
| 0.021 | 0.205 | 0.106 | Amidase inhibitor | 0.106 0.021 CHEMBL3542202 | CHEMBL3542202 | |
| 0.02 | 0.205 | 0.174 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.174 0.005 CHEMBL237987 | CHEMBL237987 | |
| 0.052 | 0.24 | 0.123 | D-Ala-D-Ala ligase inhibitor | 0.123 0.012 CHEMBL237987 | CHEMBL237987 | |
| 0.072 | 0.27 | 0.21 | MAP kinase kinase 2 inhibitor | 0.21 0.075 CHEMBL237987 | CHEMBL237987 | |
| 0.011 | 0.209 | 0.053 | Peroxisome proliferator-activated receptor delta antagonist | 0.053 0.009 CHEMBL237987 | CHEMBL237987 | |
| 0.088 | 0.304 | 0.351 | Beta lactamase inhibitor | 0.217 0.175 CHEMBL392363 0.351 0.115 CHEMBL237987 | CHEMBL237987 | |
| 0.012 | 0.23 | 0.029 | Thrombin receptor antagonist | 0.029 0.019 CHEMBL3542202 | CHEMBL3542202 | |
| 0.096 | 0.315 | 0.173 | Histone acetyltransferase inhibitor | 0.173 0.11 CHEMBL237987 | CHEMBL237987 | |
| 0.005 | 0.225 | 0.034 | HCV NS5B polymerase inhibitor | 0.034 0.019 CHEMBL237987 | CHEMBL237987 | |
| 0.004 | 0.237 | 0.034 | CXC chemokine 2 receptor antagonist | 0.034 0.01 CHEMBL237987 | CHEMBL237987 | |
| 0.048 | 0.284 | 0.337 | Aryl hydrocarbon receptor agonist | 0.337 0.051 CHEMBL237987 | CHEMBL237987 | |
| 0.022 | 0.259 | 0.096 | Factor IXa inhibitor | 0.091 0.012 CHEMBL3542202 0.096 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.031 | 0.269 | 0.193 | Urease inhibitor | 0.105 0.061 CHEMBL3542202 0.193 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.015 | 0.259 | 0.091 | Diacylglycerol O-acyltransferase inhibitor | 0.091 0.01 CHEMBL237987 | CHEMBL237987 | |
| 0.108 | 0.352 | 0.408 | Transcription factor inhibitor | 0.408 0.106 CHEMBL237987 | CHEMBL237987 | |
| 0.03 | 0.274 | 0.095 | Potassium channel large-conductance Ca-activated activator | 0.095 0.026 CHEMBL237987 | CHEMBL237987 | |
| 0.012 | 0.261 | 0.05 | Retinoic acid alpha receptor agonist | 0.05 0.014 CHEMBL237987 | CHEMBL237987 | |
| 0.094 | 0.344 | 0.43 | DNA polymerase beta inhibitor | 0.43 0.108 CHEMBL237987 | CHEMBL237987 | |
| 0.021 | 0.272 | 0.057 | I kappa B kinase 2 inhibitor | 0.057 0.054 CHEMBL237987 | CHEMBL237987 | |
| 0.055 | 0.307 | 0.128 | Protein kinase (CK1) gamma 3 inhibitor | 0.128 0.116 CHEMBL237987 | CHEMBL237987 | |
| 0.051 | 0.305 | 0.135 | TRPA1 agonist | 0.135 0.043 CHEMBL237987 | CHEMBL237987 | |
| 0.013 | 0.27 | 0.063 | TRPA1 antagonist | 0.063 0.04 CHEMBL237987 | CHEMBL237987 | |
| 0.059 | 0.319 | 0.294 | Hexokinase inhibitor | 0.294 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.017 | 0.281 | 0.075 | Sphingosine 1-phosphate receptor 3 antagonist | 0.075 0.021 CHEMBL3542202 0.07 0.025 CHEMBL237987 | CHEMBL3542202 | |
| 0.005 | 0.272 | 0.063 | Farnesoid X receptor agonist | 0.063 0.009 CHEMBL237987 | CHEMBL237987 | |
| 0.02 | 0.291 | 0.086 | Heparanase inhibitor | 0.086 0.005 CHEMBL237987 | CHEMBL237987 | |
| 0.025 | 0.297 | 0.081 | I kappa B kinase inhibitor | 0.081 0.06 CHEMBL237987 | CHEMBL237987 | |
| 0.054 | 0.326 | 0.195 | Interleukin antagonist | 0.195 0.087 CHEMBL3542202 | CHEMBL3542202 | |
| 0.036 | 0.31 | 0.139 | Bile acid receptor antagonist | 0.139 0.01 CHEMBL237987 | CHEMBL237987 | |
| 0.008 | 0.285 | 0.057 | Prostaglandin EP2 antagonist | 0.057 0.044 CHEMBL3542202 | CHEMBL3542202 | |
| 0.044 | 0.328 | 0.222 | Cytokine production inhibitor | 0.222 0.03 CHEMBL237987 | CHEMBL237987 | |
| 0.028 | 0.314 | 0.08 | Adenine nucleotide translocase inhibitor | 0.08 0.009 CHEMBL237987 | CHEMBL237987 | |
| 0.006 | 0.291 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.023 CHEMBL237987 | CHEMBL237987 | |
| 0.025 | 0.313 | 0.049 | Alpha 1b adrenoreceptor agonist | 0.049 0.039 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.294 | 0.035 | Carnitine palmitoyltransferase inhibitor | 0.035 0.022 CHEMBL237987 | CHEMBL237987 | |
| 0.058 | 0.354 | 0.174 | Sphingosine 1-phosphate receptor 2 antagonist | 0.174 0.019 CHEMBL3542202 0.173 0.019 CHEMBL237987 | CHEMBL3542202 | |
| 0.005 | 0.301 | 0.048 | Melatonin 1 antagonist | 0.048 0.005 CHEMBL3542202 | CHEMBL3542202 | |
| 0.006 | 0.305 | 0.04 | Alpha 1a adrenoreceptor agonist | 0.04 0.007 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.303 | 0.06 | Kainate receptor antagonist | 0.06 0.016 CHEMBL237987 | CHEMBL237987 | |
| 0.068 | 0.368 | 0.208 | Thioredoxin glutathione reductase inhibitor | 0.208 0.166 CHEMBL237987 | CHEMBL237987 | |
| 0.005 | 0.306 | 0.073 | Melatonin antagonist | 0.073 0.005 CHEMBL3542202 | CHEMBL3542202 | |
| 0.073 | 0.376 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.107 CHEMBL3542202 0.183 0.021 CHEMBL237987 | CHEMBL237987 | |
| 0.045 | 0.349 | 0.11 | Interleukin 8 antagonist | 0.11 0.076 CHEMBL237987 | CHEMBL237987 | |
| 0.032 | 0.337 | 0.129 | Beta glucuronidase inhibitor | 0.129 0.038 CHEMBL237987 | CHEMBL237987 | |
| 0.021 | 0.329 | 0.06 | Pregnane X receptor antagonist | 0.06 0.032 CHEMBL237987 | CHEMBL237987 | |
| 0.028 | 0.337 | 0.332 | Ferrochelatase inhibitor | 0.262 0.012 CHEMBL3542202 0.332 0.005 CHEMBL237987 | CHEMBL237987 | |
| 0.028 | 0.339 | 0.059 | Histone deacetylase SIRT3 inhibitor | 0.059 0.052 CHEMBL3542202 | CHEMBL3542202 | |
| 0.057 | 0.37 | 0.27 | Streptokinase A inhibitor | 0.27 0.092 CHEMBL237987 | CHEMBL237987 | |
| 0.084 | 0.397 | 0.161 | Catenin beta inhibitor | 0.161 0.081 CHEMBL237987 | CHEMBL237987 | |
| 0.007 | 0.323 | 0.034 | Alpha 1d adrenoreceptor agonist | 0.034 0.033 CHEMBL3542202 | CHEMBL3542202 | |
| 0.02 | 0.343 | 0.139 | M18 aspartyl aminopeptidase inhibitor | 0.139 0.058 CHEMBL3542202 | CHEMBL3542202 | |
| 0.029 | 0.352 | 0.092 | Uric acid excretion stimulant | 0.092 0.063 CHEMBL237987 | CHEMBL237987 | |
| 0.035 | 0.36 | 0.158 | Pyruvate kinase inhibitor | 0.158 0.108 CHEMBL237987 | CHEMBL237987 | |
| 0.005 | 0.335 | 0.036 | Prostaglandin EP4 antagonist | 0.036 0.012 CHEMBL237987 | CHEMBL237987 | |
| 0.04 | 0.371 | 0.146 | NADPH oxidase inhibitor | 0.146 0.057 CHEMBL237987 | CHEMBL237987 | |
| 0.06 | 0.394 | 0.282 | 5 Hydroxytryptamine 1E antagonist | 0.282 0.043 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.338 | 0.032 | NMDA receptor glycine site antagonist | 0.032 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.039 | 0.376 | 0.192 | Aldehyde dehydrogenase inhibitor | 0.192 0.03 CHEMBL237987 | CHEMBL237987 | |
| 0.042 | 0.379 | 0.131 | Heat shock protein 90 alpha antagonist | 0.131 0.11 CHEMBL237987 | CHEMBL237987 | |
| 0.008 | 0.347 | 0.045 | RNA-directed RNA polymerase inhibitor | 0.045 0.015 CHEMBL237987 | CHEMBL237987 | |
| 0.024 | 0.366 | 0.14 | Peroxisome proliferator-activated receptor gamma antagonist | 0.14 0.007 CHEMBL237987 | CHEMBL237987 | |
| 0.002 | 0.346 | 0.019 | Kainate receptor 1 antagonist | 0.019 0.016 CHEMBL237987 | CHEMBL237987 | |
| 0.06 | 0.407 | 0.137 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.137 0.099 CHEMBL237987 | CHEMBL237987 | |
| 0.007 | 0.357 | 0.131 | Acetylcholine M2 receptor antagonist | 0.131 0.014 CHEMBL3542202 | CHEMBL3542202 | |
| 0.013 | 0.369 | 0.133 | Nicotinic acid receptor 1 agonist | 0.133 0.005 CHEMBL237987 | CHEMBL237987 | |
| 0.002 | 0.36 | 0.031 | Prostaglandin E2 agonist | 0.031 0.01 CHEMBL237987 | CHEMBL237987 | |
| 0.004 | 0.365 | 0.019 | Calcium-sensing receptor antagonist | 0.019 0.009 CHEMBL3542202 | CHEMBL3542202 | |
| 0.034 | 0.397 | 0.116 | Lanosterol 14 alpha demethylase inhibitor | 0.116 0.034 CHEMBL3542202 | CHEMBL3542202 | |
| 0.006 | 0.372 | 0.07 | NMDA 2C receptor antagonist | 0.07 0.033 CHEMBL3542202 | CHEMBL3542202 | |
| 0.023 | 0.39 | 0.09 | Gastric antisecretory | 0.09 0.078 CHEMBL3542202 | CHEMBL3542202 | |
| 0.038 | 0.405 | 0.247 | Cyclooxygenase 3 inhibitor | 0.247 0.009 CHEMBL3542202 | CHEMBL3542202 | |
| 0.025 | 0.394 | 0.258 | Acetylcholine muscarinic antagonist | 0.258 0.013 CHEMBL3542202 | CHEMBL3542202 | |
| 0.039 | 0.409 | 0.162 | Hypolipemic | 0.162 0.125 CHEMBL3542202 | CHEMBL3542202 | |
| 0.04 | 0.412 | 0.1 | Toll-Like receptor 3 antagonist | 0.1 0.051 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.377 | 0.046 | Oleamide hydrolase inhibitor | 0.046 0.031 CHEMBL3542202 | CHEMBL3542202 | |
| 0.026 | 0.4 | 0.095 | Phosphodiesterase XI inhibitor | 0.095 0.037 CHEMBL237772 | CHEMBL237772 | |
| 0.026 | 0.4 | 0.095 | Phosphodiesterase 11A inhibitor | 0.095 0.037 CHEMBL237772 | CHEMBL237772 | |
| 0.019 | 0.399 | 0.094 | Dihydroorotate oxidase inhibitor | 0.058 0.032 CHEMBL3542202 0.094 0.006 CHEMBL237987 | CHEMBL237987 | |
| 0.051 | 0.433 | 0.265 | Alpha-glucosidase inhibitor | 0.265 0.178 CHEMBL237987 | CHEMBL237987 | |
| 0.045 | 0.428 | 0.169 | Hemostatic | 0.14 0.081 CHEMBL3542202 0.169 0.049 CHEMBL237987 | CHEMBL237987 | |
| 0.022 | 0.406 | 0.147 | Cystathionine beta-synthase inhibitor | 0.147 0.042 CHEMBL237987 | CHEMBL237987 | |
| 0.019 | 0.404 | 0.22 | Potassium channel (Ca-activated) activator | 0.22 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.014 | 0.4 | 0.043 | Leukotriene C4 antagonist | 0.043 0.018 CHEMBL237987 | CHEMBL237987 | |
| 0.021 | 0.413 | 0.065 | Leukotriene C antagonist | 0.065 0.02 CHEMBL237987 | CHEMBL237987 | |
| 0.031 | 0.426 | 0.316 | Acetylcholine M1 receptor antagonist | 0.316 0.012 CHEMBL3542202 | CHEMBL3542202 | |
| 0.084 | 0.486 | 0.4 | Calcium channel activator | 0.4 0.025 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.408 | 0.04 | Methionyl aminopeptidase 1 inhibitor | 0.04 0.012 CHEMBL3542202 | CHEMBL3542202 | |
| 0.106 | 0.512 | 0.598 | 5 Hydroxytryptamine release inhibitor | 0.395 0.081 CHEMBL3542202 0.598 0.011 CHEMBL237987 | CHEMBL237987 | |
| 0.023 | 0.436 | 0.126 | Neurotrophic factor | 0.126 0.086 CHEMBL3542202 | CHEMBL3542202 | |
| 0.014 | 0.428 | 0.227 | M17 leucyl aminopeptidase inhibitor | 0.227 0.025 CHEMBL237987 | CHEMBL237987 | |
| 0.029 | 0.445 | 0.194 | Dual specificity phosphatase 3 inhibitor | 0.194 0.064 CHEMBL237987 | CHEMBL237987 | |
| 0.103 | 0.52 | 0.246 | 5 Hydroxytryptamine uptake stimulant | 0.192 0.169 CHEMBL3542202 0.246 0.085 CHEMBL237987 | CHEMBL237987 | |
| 0.013 | 0.435 | 0.067 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.067 0.005 CHEMBL237987 | CHEMBL237987 | |
| 0.003 | 0.427 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.009 CHEMBL3542202 | CHEMBL3542202 | |
| 0.047 | 0.471 | 0.525 | Calpain 2 inhibitor | 0.525 0.018 CHEMBL3542202 0.309 0.109 CHEMBL237987 | CHEMBL3542202 | |
| 0.05 | 0.474 | 0.128 | CF transmembrane conductance regulator agonist | 0.128 0.123 CHEMBL237987 | CHEMBL237987 | |
| 0.008 | 0.434 | 0.048 | Carbonic anhydrase XIV inhibitor | 0.048 0.035 CHEMBL3542202 | CHEMBL3542202 | |
| 0.039 | 0.471 | 0.084 | Hematopoietic | 0.084 0.063 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.44 | 0.04 | Sphingosine 1-phosphate receptor agonist | 0.04 0.037 CHEMBL237987 | CHEMBL237987 | |
| 0.02 | 0.458 | 0.101 | MAP kinase kinase 1 inhibitor | 0.101 0.055 CHEMBL237987 | CHEMBL237987 | |
| 0.004 | 0.442 | 0.107 | NMDA 2 receptor antagonist | 0.107 0.029 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.443 | 0.025 | Calcium-sensing receptor agonist | 0.025 0.021 CHEMBL237987 | CHEMBL237987 | |
| 0.009 | 0.449 | 0.045 | Plasminogen activator inhibitor antagonist | 0.045 0.039 CHEMBL237987 | CHEMBL237987 | |
| 0.003 | 0.447 | 0.032 | Prostaglandin agonist | 0.032 0.019 CHEMBL237987 | CHEMBL237987 | |
| 0.003 | 0.449 | 0.153 | Diamine oxidase inhibitor | 0.153 0.003 CHEMBL3542202 | CHEMBL3542202 | |
| 0.019 | 0.473 | 0.161 | Mcl-1 antagonist | 0.161 0.08 CHEMBL237987 | CHEMBL237987 | |
| 0.099 | 0.556 | 0.197 | 5 Hydroxytryptamine 3E antagonist | 0.197 0.068 CHEMBL3542202 | CHEMBL3542202 | |
| 0.027 | 0.485 | 0.225 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.225 0.087 CHEMBL237987 | CHEMBL237987 | |
| 0.005 | 0.465 | 0.238 | Acetylcholine M3 receptor antagonist | 0.238 0.005 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.466 | 0.051 | Methionyl aminopeptidase 2 inhibitor | 0.051 0.006 CHEMBL237987 | CHEMBL237987 | |
| 0.007 | 0.478 | 0.054 | Melatonin 1 agonist | 0.054 0.008 CHEMBL3542202 | CHEMBL3542202 | |
| 0.006 | 0.489 | 0.094 | NMDA receptor glycine site agonist | 0.094 0.02 CHEMBL3542202 0.092 0.021 CHEMBL237987 | CHEMBL3542202 | |
| 0.005 | 0.493 | 0.046 | Thymidylate synthase inhibitor | 0.046 0.033 CHEMBL237987 | CHEMBL237987 | |
| 0.023 | 0.512 | 0.132 | Mannose-6-phosphate isomerase inhibitor | 0.132 0.083 CHEMBL237987 | CHEMBL237987 | |
| 0.019 | 0.512 | 0.206 | Acetylcholine antagonist | 0.206 0.029 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.499 | 0.054 | Melatonin agonist | 0.054 0.008 CHEMBL3542202 | CHEMBL3542202 | |
| 0.023 | 0.521 | 0.164 | Nav1.3 sodium channel blocker | 0.164 0.04 CHEMBL3542202 | CHEMBL3542202 | |
| 0.028 | 0.526 | 0.13 | Sphingosine 1-phosphate receptor 4 antagonist | 0.108 0.098 CHEMBL3542202 0.13 0.056 CHEMBL237987 | CHEMBL237987 | |
| 0.004 | 0.504 | 0.095 | NMDA 2A receptor antagonist | 0.095 0.015 CHEMBL3542202 | CHEMBL3542202 | |
| 0.019 | 0.519 | 0.209 | Cholinergic antagonist | 0.209 0.03 CHEMBL3542202 | CHEMBL3542202 | |
| 0.021 | 0.527 | 0.08 | HIV-1 integrase (Overall Integration) inhibitor | 0.08 0.079 CHEMBL3542202 | CHEMBL3542202 | |
| 0.023 | 0.53 | 0.147 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.06 CHEMBL3542202 0.147 0.028 CHEMBL237987 | CHEMBL237987 | |
| 0.002 | 0.509 | 0.023 | Nicotinic acid receptor 1 antagonist | 0.023 0.006 CHEMBL237987 | CHEMBL237987 | |
| 0.019 | 0.528 | 0.102 | Alpha 2b adrenoreceptor antagonist | 0.102 0.073 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.515 | 0.098 | Protein kinase (CK2) inhibitor | 0.098 0.065 CHEMBL237987 | CHEMBL237987 | |
| 0.023 | 0.534 | 0.163 | Dual specificity phosphatase inhibitor | 0.163 0.081 CHEMBL237987 | CHEMBL237987 | |
| 0.026 | 0.545 | 0.135 | Amyloid beta precursor protein antagonist | 0.135 0.119 CHEMBL237987 | CHEMBL237987 | |
| 0.03 | 0.555 | 0.247 | 12-Lipoxygenase inhibitor | 0.247 0.111 CHEMBL237987 | CHEMBL237987 | |
| 0.016 | 0.542 | 0.116 | Alkaline phosphatase inhibitor | 0.116 0.091 CHEMBL237987 | CHEMBL237987 | |
| 0.006 | 0.534 | 0.064 | Alpha 1 adrenoreceptor agonist | 0.064 0.032 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.534 | 0.113 | Protein kinase (CK2) alpha inhibitor | 0.113 0.066 CHEMBL237987 | CHEMBL237987 | |
| 0.005 | 0.539 | 0.13 | NMDA receptor antagonist | 0.13 0.031 CHEMBL3542202 | CHEMBL3542202 | |
| 0.027 | 0.562 | 0.2 | Peroxidase inhibitor | 0.2 0.059 CHEMBL3542202 | CHEMBL3542202 | |
| 0.045 | 0.579 | 0.227 | Gastrin inhibitor | 0.227 0.11 CHEMBL3542202 0.19 0.164 CHEMBL237987 | CHEMBL3542202 | |
| 0.009 | 0.544 | 0.129 | NMDA receptor agonist | 0.129 0.011 CHEMBL3542202 0.092 0.022 CHEMBL237987 | CHEMBL3542202 | |
| 0.027 | 0.565 | 0.148 | Non-steroidal antiinflammatory agent | 0.148 0.117 CHEMBL237987 | CHEMBL237987 | |
| 0.036 | 0.573 | 0.181 | Interferon gamma antagonist | 0.181 0.049 CHEMBL237987 | CHEMBL237987 | |
| 0.007 | 0.55 | 0.08 | Potassium channel (Inward rectifier) blocker | 0.08 0.012 CHEMBL3542202 | CHEMBL3542202 | |
| 0.015 | 0.561 | 0.122 | Caspase 3 inhibitor | 0.122 0.057 CHEMBL237987 | CHEMBL237987 | |
| 0.078 | 0.625 | 0.379 | Peptidyltransferase inhibitor | 0.379 0.009 CHEMBL3542202 | CHEMBL3542202 | |
| 0.01 | 0.563 | 0.52 | Adrenaline antagonist | 0.52 0.005 CHEMBL3542202 | CHEMBL3542202 | |
| 0.011 | 0.564 | 0.521 | Antiadrenergic | 0.521 0.005 CHEMBL3542202 | CHEMBL3542202 | |
| 0.036 | 0.589 | 0.169 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.169 0.109 CHEMBL3542202 | CHEMBL3542202 | |
| 0.042 | 0.6 | 0.188 | Hypoglycemic | 0.188 0.125 CHEMBL3542202 | CHEMBL3542202 | |
| 0.057 | 0.62 | 0.217 | 5 Hydroxytryptamine release stimulant | 0.217 0.108 CHEMBL3542202 | CHEMBL3542202 | |
| 0.037 | 0.6 | 0.246 | Transcription factor STAT inhibitor | 0.212 0.121 CHEMBL3542202 0.246 0.089 CHEMBL237987 | CHEMBL237987 | |
| 0.002 | 0.57 | 0.056 | Carbonic anhydrase IV inhibitor | 0.056 0.021 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.573 | 0.109 | Alpha adrenoreceptor agonist | 0.109 0.024 CHEMBL3542202 | CHEMBL3542202 | |
| 0.02 | 0.595 | 0.31 | Calpain inhibitor | 0.31 0.026 CHEMBL3542202 | CHEMBL3542202 | |
| 0.014 | 0.594 | 0.065 | Purinergic P2X1 antagonist | 0.065 0.036 CHEMBL237987 | CHEMBL237987 | |
| 0.007 | 0.588 | 0.095 | Alkylator | 0.095 0.094 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.587 | 0.056 | Biliverdin reductase inhibitor | 0.056 0.044 CHEMBL237987 | CHEMBL237987 | |
| 0.039 | 0.624 | 0.592 | Toll-Like receptor 7 agonist | 0.592 0.018 CHEMBL3542202 | CHEMBL3542202 | |
| 0.015 | 0.601 | 0.077 | Keratolytic | 0.077 0.052 CHEMBL237987 | CHEMBL237987 | |
| 0.001 | 0.588 | 0.242 | Beta 3 adrenoreceptor agonist | 0.242 0.002 CHEMBL3542202 | CHEMBL3542202 | |
| 0.01 | 0.601 | 0.129 | Protein-tyrosine phosphatase inhibitor | 0.129 0.102 CHEMBL237987 | CHEMBL237987 | |
| 0.018 | 0.61 | 0.138 | Electrolyte absorption antagonist | 0.138 0.025 CHEMBL237987 | CHEMBL237987 | |
| 0.021 | 0.619 | 0.195 | Succinate dehydrogenase inhibitor | 0.195 0.053 CHEMBL237987 | CHEMBL237987 | |
| 0.036 | 0.64 | 0.592 | Toll-Like receptor agonist | 0.592 0.018 CHEMBL3542202 | CHEMBL3542202 | |
| 0.029 | 0.635 | 0.146 | Phospholipase C inhibitor | 0.146 0.115 CHEMBL3542202 | CHEMBL3542202 | |
| 0.028 | 0.639 | 0.15 | Interleukin 4 antagonist | 0.15 0.05 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.618 | 0.109 | Catalase inhibitor | 0.109 0.036 CHEMBL3542202 0.064 0.06 CHEMBL237987 | CHEMBL3542202 | |
| 0.009 | 0.623 | 0.076 | Calcium antagonist | 0.076 0.067 CHEMBL3542202 | CHEMBL3542202 | |
| 0.028 | 0.644 | 0.094 | Estrogen-related receptor beta agonist | 0.094 0.032 CHEMBL3542202 | CHEMBL3542202 | |
| 0.008 | 0.635 | 0.14 | Carbonic anhydrase stimulant | 0.14 0.012 CHEMBL3542202 | CHEMBL3542202 | |
| 0.002 | 0.631 | 0.169 | Beta 1 adrenoreceptor agonist | 0.169 0.002 CHEMBL3542202 | CHEMBL3542202 | |
| 0.008 | 0.638 | 0.098 | Nitric-oxide synthase inhibitor | 0.098 0.064 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.637 | 0.042 | Histamine H2 receptor agonist | 0.042 0.031 CHEMBL3542202 | CHEMBL3542202 | |
| 0.006 | 0.64 | 0.199 | Beta 2 adrenoreceptor agonist | 0.199 0.002 CHEMBL3542202 | CHEMBL3542202 | |
| 0.014 | 0.648 | 0.108 | Toll-Like receptor 2 antagonist | 0.108 0.092 CHEMBL3542202 | CHEMBL3542202 | |
| 0.016 | 0.652 | 0.13 | Triose-phosphate isomerase inhibitor | 0.13 0.027 CHEMBL237987 | CHEMBL237987 | |
| 0.022 | 0.659 | 0.227 | Transcription factor STAT3 inhibitor | 0.227 0.105 CHEMBL237987 | CHEMBL237987 | |
| 0.021 | 0.667 | 0.133 | Melanin inhibitor | 0.133 0.109 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.651 | 0.056 | Sphingosine kinase inhibitor | 0.056 0.047 CHEMBL3542202 | CHEMBL3542202 | |
| 0.018 | 0.665 | 0.081 | NADH dehydrogenase inhibitor | 0.081 0.073 CHEMBL237987 | CHEMBL237987 | |
| 0.004 | 0.652 | 0.13 | Monophenol monooxygenase inhibitor | 0.13 0.056 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.653 | 0.036 | Glutamate (mGluR3) agonist | 0.036 0.015 CHEMBL237987 | CHEMBL237987 | |
| 0.001 | 0.655 | 0.013 | Melatonin receptor 1A antagonist | 0.013 0.01 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.666 | 0.297 | Beta adrenoreceptor agonist | 0.297 0.002 CHEMBL3542202 | CHEMBL3542202 | |
| 0.01 | 0.671 | 0.403 | Beta 3 adrenoreceptor antagonist | 0.403 0.002 CHEMBL3542202 | CHEMBL3542202 | |
| 0.034 | 0.697 | 0.261 | Insulysin inhibitor | 0.261 0.086 CHEMBL3542202 | CHEMBL3542202 | |
| 0.015 | 0.679 | 0.124 | Neuropeptide Y1 antagonist | 0.124 0.112 CHEMBL3542202 | CHEMBL3542202 | |
| 0.028 | 0.695 | 0.145 | Neurotensin receptor agonist | 0.145 0.113 CHEMBL3542202 | CHEMBL3542202 | |
| 0.032 | 0.699 | 0.374 | Histamine release inhibitor | 0.356 0.097 CHEMBL3542202 0.374 0.089 CHEMBL237987 | CHEMBL237987 | |
| 0.025 | 0.697 | 0.27 | Cholesterol antagonist | 0.27 0.112 CHEMBL237987 | CHEMBL237987 | |
| 0.011 | 0.682 | 0.092 | UDP-glucose 4-epimerase inhibitor | 0.092 0.07 CHEMBL3542202 | CHEMBL3542202 | |
| 0.017 | 0.691 | 0.191 | Carbonic anhydrase XV inhibitor | 0.191 0.02 CHEMBL3542202 | CHEMBL3542202 | |
| 0.002 | 0.683 | 0.025 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 CHEMBL237987 | CHEMBL237987 | |
| 0.008 | 0.692 | 0.142 | Falcipain 3 inhibitor | 0.142 0.04 CHEMBL3542202 | CHEMBL3542202 | |
| 0.014 | 0.701 | 0.253 | Adenylate cyclase inhibitor | 0.253 0.019 CHEMBL3542202 0.108 0.078 CHEMBL237987 | CHEMBL3542202 | |
| 0.017 | 0.71 | 0.091 | Nav1.4 sodium channel blocker | 0.091 0.09 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.703 | 0.146 | Neuraminidase inhibitor | 0.146 0.006 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.706 | 0.094 | Carbonic anhydrase VA inhibitor | 0.094 0.028 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.707 | 0.132 | Phospholipase A2 inhibitor | 0.132 0.097 CHEMBL3542202 | CHEMBL3542202 | |
| 0.006 | 0.709 | 0.078 | Aminopeptidase I inhibitor | 0.078 0.044 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.708 | 0.448 | Adrenaline agonist | 0.448 0.003 CHEMBL3542202 | CHEMBL3542202 | |
| 0.015 | 0.723 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.061 0.023 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.712 | 0.037 | Toll-Like receptor 2 agonist | 0.037 0.032 CHEMBL3542202 | CHEMBL3542202 | |
| 0.074 | 0.785 | 0.647 | Calcium channel L-type activator | 0.647 0.004 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.719 | 0.314 | Anesthetic local | 0.314 0.011 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.721 | 0.152 | Neuraminidase (influenza) inhibitor | 0.152 0.007 CHEMBL3542202 | CHEMBL3542202 | |
| 0.006 | 0.723 | 0.194 | Anesthetic general | 0.194 0.077 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.72 | 0.097 | Nicotinic acid receptor agonist | 0.097 0.005 CHEMBL237987 | CHEMBL237987 | |
| 0.004 | 0.722 | 0.101 | Carbonic anhydrase V inhibitor | 0.101 0.027 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.723 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.059 0.024 CHEMBL3542202 | CHEMBL3542202 | |
| 0.006 | 0.728 | 0.049 | AICAR transformylase inhibitor | 0.049 0.024 CHEMBL3542202 | CHEMBL3542202 | |
| 0.04 | 0.763 | 0.287 | Caspase 9 stimulant | 0.287 0.209 CHEMBL3542202 | CHEMBL3542202 | |
| 0.013 | 0.738 | 0.353 | Transcription factor NF kappa B inhibitor | 0.353 0.076 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.731 | 0.368 | Beta 2 adrenoreceptor antagonist | 0.368 0.002 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.736 | 0.29 | Phenylalanine 4-hydroxylase inhibitor | 0.29 0.004 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.736 | 0.317 | Beta 1 adrenoreceptor antagonist | 0.317 0.002 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.739 | 0.382 | Psychostimulant | 0.382 0.025 CHEMBL3542202 | CHEMBL3542202 | |
| 0.017 | 0.751 | 0.122 | Electron transport complex I inhibitor | 0.122 0.044 CHEMBL3542202 | CHEMBL3542202 | |
| 0.014 | 0.752 | 0.139 | Carbonic anhydrase III inhibitor | 0.139 0.033 CHEMBL3542202 | CHEMBL3542202 | |
| 0.008 | 0.748 | 0.331 | Insulin sensitizer | 0.331 0.011 CHEMBL3542202 | CHEMBL3542202 | |
| 0.009 | 0.758 | 0.316 | Alpha-N-acetylglucosaminidase inhibitor | 0.316 0.015 CHEMBL3542202 | CHEMBL3542202 | |
| 0.007 | 0.758 | 0.078 | GABA B receptor agonist | 0.078 0.046 CHEMBL3542202 | CHEMBL3542202 | |
| 0.012 | 0.763 | 0.105 | Acetylcholine release stimulant | 0.105 0.076 CHEMBL3542202 | CHEMBL3542202 | |
| 0.011 | 0.766 | 0.141 | Sphingomyelinase inhibitor | 0.141 0.029 CHEMBL3542202 | CHEMBL3542202 | |
| 0.002 | 0.758 | 0.059 | Carbonic anhydrase VB inhibitor | 0.059 0.036 CHEMBL3542202 | CHEMBL3542202 | |
| 0.008 | 0.765 | 0.506 | Spasmolytic | 0.506 0.022 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.765 | 0.07 | Melatonin 2 agonist | 0.07 0.006 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.772 | 0.071 | GABA aminotransferase inhibitor | 0.071 0.061 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.782 | 0.335 | Beta adrenoreceptor antagonist | 0.335 0.003 CHEMBL3542202 | CHEMBL3542202 | |
| 0.016 | 0.802 | 0.209 | Immunosuppressant | 0.209 0.187 CHEMBL3542202 | CHEMBL3542202 | |
| 0.006 | 0.793 | 0.082 | Histamine H2 receptor antagonist | 0.082 0.062 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.796 | 0.079 | Nicotinic acid receptor 2 agonist | 0.079 0.008 CHEMBL237987 | CHEMBL237987 | |
| 0.01 | 0.807 | 0.151 | Insulin secretagoues | 0.151 0.074 CHEMBL3542202 | CHEMBL3542202 | |
| 0.013 | 0.81 | 0.235 | Hypoxia-inducible factor 1 alpha inhibitor | 0.235 0.114 CHEMBL3542202 | CHEMBL3542202 | |
| 0.009 | 0.813 | 0.14 | Antibacterial (Helicobacter pylori) | 0.14 0.055 CHEMBL3542202 | CHEMBL3542202 | |
| 0.009 | 0.814 | 0.092 | Aminopeptidase B inhibitor | 0.092 0.071 CHEMBL3542202 | CHEMBL3542202 | |
| 0.011 | 0.815 | 0.088 | Somatostatin 1 agonist | 0.088 0.043 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.81 | 0.088 | Maillard reaction inhibitor | 0.088 0.021 CHEMBL3542202 | CHEMBL3542202 | |
| 0.012 | 0.817 | 0.051 | Vanilloid 2 antagonist | 0.051 0.039 CHEMBL3542202 | CHEMBL3542202 | |
| 0.01 | 0.815 | 0.078 | Carbonic anhydrase VI inhibitor | 0.078 0.059 CHEMBL3542202 | CHEMBL3542202 | |
| 0.009 | 0.82 | 0.258 | Antithrombotic | 0.258 0.12 CHEMBL3542202 | CHEMBL3542202 | |
| 0.032 | 0.845 | 0.211 | Tyrosine 3 hydroxylase inhibitor | 0.211 0.117 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.823 | 0.037 | Membrane dipeptidase inhibitor | 0.037 0.032 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.832 | 0.143 | Aminoacyl-tRNA synthetase inhibitor | 0.143 0.021 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.831 | 0.195 | Expectorant | 0.195 0.021 CHEMBL3542202 | CHEMBL3542202 | |
| 0.009 | 0.839 | 0.136 | Anabolic | 0.136 0.026 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.834 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.022 CHEMBL3526965 0.027 0.023 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.844 | 0.078 | Neuraminidase (Influenza A) inhibitor | 0.078 0.005 CHEMBL3542202 | CHEMBL3542202 | |
| 0.013 | 0.857 | 0.403 | Vasodilator, coronary | 0.403 0.034 CHEMBL3542202 | CHEMBL3542202 | |
| 0 | 0.844 | 0.018 | Ileal bile acid transport inhibitor | 0.018 0.011 CHEMBL3542202 | CHEMBL3542202 | |
| 0.001 | 0.848 | 0.038 | Neuraminidase (Influenza B) inhibitor | 0.038 0.003 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.854 | 0.222 | Mucolytic | 0.222 0.009 CHEMBL3542202 | CHEMBL3542202 | |
| 0.002 | 0.852 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.02 CHEMBL3542202 | CHEMBL3542202 | |
| 0.007 | 0.865 | 0.241 | Vasodilator | 0.241 0.074 CHEMBL3542202 | CHEMBL3542202 | |
| 0.002 | 0.867 | 0.099 | Glutamate decarboxylase inhibitor | 0.099 0.03 CHEMBL3542202 | CHEMBL3542202 | |
| 0.01 | 0.882 | 0.551 | Vasodilator, peripheral | 0.551 0.021 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.878 | 0.69 | Bronchodilator | 0.69 0.004 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.88 | 0.061 | Alpha-mannosidase inhibitor | 0.061 0.026 CHEMBL3542202 | CHEMBL3542202 | |
| 0.007 | 0.89 | 0.13 | Cell wall synthesis inhibitor | 0.13 0.086 CHEMBL3542202 | CHEMBL3542202 | |
| 0.002 | 0.886 | 0.051 | Mannosidase inhibitor | 0.051 0.025 CHEMBL3542202 | CHEMBL3542202 | |
| 0.023 | 0.908 | 0.25 | Sodium/bile acid cotransporter inhibitor | 0.25 0.128 CHEMBL3542202 | CHEMBL3542202 | |
| 0.001 | 0.887 | 0.016 | Adenosine A2 receptor agonist | 0.016 0.012 CHEMBL3542202 | CHEMBL3542202 | |
| 0.004 | 0.895 | 0.273 | Immunostimulant | 0.273 0.087 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.903 | 0.067 | Interferon inducer | 0.067 0.039 CHEMBL3542202 | CHEMBL3542202 | |
| 0.003 | 0.919 | 0.078 | Interferon agonist | 0.078 0.055 CHEMBL3542202 | CHEMBL3542202 | |
| 0.005 | 0.925 | 0.222 | Adenylate cyclase stimulant | 0.222 0.007 CHEMBL3542202 | CHEMBL3542202 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |